Medpharm

MedPharm is a contract development and manufacturing organization (CDMO) specializing in topical, transdermal, and transepithelial drug products. Founded in 1999 within the scientific community at King's College London, MedPharm has grown from its academic origins into a global CDMO with facilities in Guildford, UK, and Durham, North Carolina, USA. The company partners with pharmaceutical and biotechnology companies to address complex challenges and advance drug products from early development through clinical and commercial manufacturing. MedPharm's capabilities span formulation development, in vitro performance testing using proprietary platforms and validated models, GMP manufacturing, and clinical trial material supply. The company's expertise covers dermal, transdermal, ophthalmic, respiratory, mucosal, and ungual dosage forms. In July 2024, MedPharm merged with Tergus Pharma to form a leading end-to-end CDMO with combined scientific, clinical trial manufacturing, and commercial production capabilities.